Jefferies & Co. has a $40 price target and a Neutral rating on UnitedHealth Group UNH.
In a note sent to clients Jefferies writes, "UNH remains committed to building robust offerings leveraging its information assets, connectivity/technology capabilities, and clinical care models. It's leading positions across books of business allow it to leverage scale, pricing, relationships, and market intelligence. Short-term, UNH's highly complex entity structure makes MCR precision more onerous for it than others."
Shares of UNH lost 7 cents yesterday to close at $36.52.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in